These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 11346105)
1. The efficacy of an antibiotic protocol for community-acquired pneumonia. Dobbin CJ; Duggan CJ; Barnes DJ Med J Aust; 2001 Apr; 174(7):333-7. PubMed ID: 11346105 [TBL] [Abstract][Full Text] [Related]
2. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database. Brown RB; Iannini P; Gross P; Kunkel M Chest; 2003 May; 123(5):1503-11. PubMed ID: 12740267 [TBL] [Abstract][Full Text] [Related]
3. Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study. Høgli JU; Garcia BH; Svendsen K; Skogen V; Småbrekke L BMC Pulm Med; 2020 Jun; 20(1):169. PubMed ID: 32539706 [TBL] [Abstract][Full Text] [Related]
4. A clinical and economic study of community-acquired pneumonia between single versus combination therapy. Hasali MA; Ibrahim MI; Sulaiman SA; Ahmad Z; Hasali JB Pharm World Sci; 2005 Jun; 27(3):249-53. PubMed ID: 16096896 [TBL] [Abstract][Full Text] [Related]
5. Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia. Clark LC; Davis CW Am J Health Syst Pharm; 2000 Nov; 57 Suppl 3():S10-3. PubMed ID: 11098314 [TBL] [Abstract][Full Text] [Related]
6. Empiric management of community-acquired pneumonia in Australian emergency departments. Maxwell DJ; McIntosh KA; Pulver LK; Easton KL Med J Aust; 2005 Nov; 183(10):520-4. PubMed ID: 16296965 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness in the hospital use of antibiotics: introductory considerations. Capri S; Dellamano R J Chemother; 1993 Oct; 5(5):348-51. PubMed ID: 8106909 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone. Rosón B; Carratalà J; Tubau F; Dorca J; Liñares J; Pallares R; Manresa F; Gudiol F Microb Drug Resist; 2001; 7(1):85-96. PubMed ID: 11310807 [TBL] [Abstract][Full Text] [Related]
9. Inpatient care of community-acquired pneumonia: the effect of antimicrobial guidelines on clinical outcomes and drug costs in Canadian teaching hospitals. Marras TK; Jamieson L; Chan CK Can Respir J; 2004 Mar; 11(2):131-7. PubMed ID: 15045044 [TBL] [Abstract][Full Text] [Related]
10. Penicillin treatment for patients with Community-Acquired Pneumonia in Denmark: a retrospective cohort study. Egelund GB; Jensen AV; Andersen SB; Petersen PT; Lindhardt BØ; von Plessen C; Rohde G; Ravn P BMC Pulm Med; 2017 Apr; 17(1):66. PubMed ID: 28427381 [TBL] [Abstract][Full Text] [Related]
11. Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia. Lidman C; Burman LG; Lagergren A; Ortqvist A Scand J Infect Dis; 2002; 34(12):873-9. PubMed ID: 12587618 [TBL] [Abstract][Full Text] [Related]
12. [Estimation of the clinical and pharmacoeconomic efficiency of treatment in patients with community-acquired pneumonia with third-generation cephalosporins]. Starodubtseva OI; Vakhrushev IaM Probl Tuberk Bolezn Legk; 2009; (6):28-9. PubMed ID: 19642570 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia. Dresser LD; Niederman MS; Paladino JA Chest; 2001 May; 119(5):1439-48. PubMed ID: 11348951 [TBL] [Abstract][Full Text] [Related]
14. Community-acquired pneumonia: impact of empirical antibiotic therapy without respiratory fluoroquinolones nor third-generation cephalosporins. Pradelli J; Risso K; de Salvador FG; Cua E; Ruimy R; Roger PM Eur J Clin Microbiol Infect Dis; 2015 Mar; 34(3):511-8. PubMed ID: 25273975 [TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of empiric antibiotics for community-acquired pneumonia. Queen MA; Myers AL; Hall M; Shah SS; Williams DJ; Auger KA; Jerardi KE; Statile AM; Tieder JS Pediatrics; 2014 Jan; 133(1):e23-9. PubMed ID: 24324001 [TBL] [Abstract][Full Text] [Related]
16. Potential for cost-savings in the care of hospitalized low-risk community-acquired pneumonia patients in China. Zhou QT; He B; Zhu H Value Health; 2009; 12(1):40-6. PubMed ID: 18637052 [TBL] [Abstract][Full Text] [Related]